A carregar...

Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the Rat

Cisplatin, a chemotherapeutic agent of choice for the treatment of solid tumors, produces hearing loss in approximately half a million new cancer patients annually in the United States. The hearing loss is due, in part, to increased generation of reactive oxygen species (ROS) in the cochlea, leading...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mukherjea, Debashree, Jajoo, Sarvesh, Whitworth, Craig, Bunch, Jennifer R., Turner, Jeremy G., Rybak, Leonard P., Ramkumar, Vickram
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2865180/
https://ncbi.nlm.nih.gov/pubmed/19052196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1307-08.2008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!